ADVERTISEMENT RETURN TO ISSUEPREVReviewNEXTTargeting the Achilles Heel of Multidrug-Resistant Cancer by Exploiting the Fitness Cost of ResistanceGergely Szakács*†, Matthew D. Hall‡, Michael M. Gottesman‡, Ahcène Boumendjel§, Remy Kachadourian∥⊥, Brian J. Day∥⊥, Hélène Baubichon-Cortay#, and Attilio ...
No comments yet
Be the first to share your thoughts!